Geoff Meacham
Stock Analyst at B of A Securities
(3.93)
# 630
Out of 4,984 analysts
258
Total ratings
57.06%
Success rate
8.08%
Average return
Main Sectors:
Stocks Rated by Geoff Meacham
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RNA Avidity Biosciences | Maintains: Buy | $56 → $65 | $40.06 | +62.26% | 7 | Sep 15, 2025 | |
| AMLX Amylyx Pharmaceuticals | Maintains: Buy | $10 → $14 | $12.76 | +9.72% | 3 | Aug 28, 2025 | |
| VIR Vir Biotechnology | Upgrades: Buy | $12 → $14 | $4.80 | +191.67% | 3 | Aug 27, 2025 | |
| ABOS Acumen Pharmaceuticals | Maintains: Buy | $10 → $9 | $1.25 | +620.00% | 5 | Aug 25, 2025 | |
| AMGN Amgen | Maintains: Neutral | $305 → $310 | $274.71 | +12.85% | 13 | Aug 6, 2025 | |
| BIIB Biogen | Maintains: Neutral | $125 → $135 | $144.87 | -6.81% | 15 | Aug 1, 2025 | |
| PTCT PTC Therapeutics | Maintains: Neutral | $40 → $50 | $60.65 | -17.56% | 9 | Jul 28, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $79 → $78 | $59.07 | +32.05% | 3 | Jul 22, 2025 | |
| RPRX Royalty Pharma | Maintains: Buy | $40 → $42 | $35.63 | +17.89% | 3 | Jul 22, 2025 | |
| BBIO BridgeBio Pharma | Maintains: Buy | $50 → $54 | $51.29 | +5.28% | 6 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $72 | $59.17 | +21.68% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $24.49 | +71.50% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $110 | $76.42 | +43.94% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $6 | $8.39 | -28.49% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $700 → $650 | $585.50 | +11.02% | 22 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $210 → $205 | $220.81 | -7.16% | 19 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $47 → $44 | $47.87 | -8.08% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $140 | $98.15 | +42.64% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $7 → $1 | $1.45 | -31.03% | 3 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $40 | $25.00 | +60.00% | 10 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $35.37 | +13.09% | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $37.57 | +152.86% | 2 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $8.10 | +208.83% | 1 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $99 → $103 | $54.39 | +89.37% | 3 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $112 → $4 | $2.90 | +37.93% | 5 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $112.26 | +11.35% | 6 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $575 | $387.15 | +48.52% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,150 → $1,100 | $760.13 | +44.71% | 9 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $120 → $20 | $12.04 | +66.11% | 3 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $31 | $12.21 | +153.89% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $145 | $81.14 | +78.70% | 6 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $177.20 | -4.06% | 3 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $48 | $23.46 | +104.60% | 2 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $68 → $60 | $46.15 | +30.01% | 8 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $10 → $8 | $5.36 | +49.25% | 4 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $17 | $0.47 | +3,513.95% | 1 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $50 → $45 | $24.05 | +87.11% | 6 | Apr 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $24 | $2.18 | +1,000.92% | 4 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $4 | $4.06 | -1.48% | 2 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $1.66 | +1,591.84% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $34 | $0.50 | +6,768.69% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $35 | $2.72 | +1,189.13% | 4 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $525 | $2.86 | +18,251.51% | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $1.30 | +3,143.24% | 1 | Oct 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $7.31 | +173.60% | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $0.51 | +3,800.92% | 2 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Underperform | $9 | $4.34 | +107.37% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $60 | $9.00 | +566.67% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7 | $4.15 | +68.67% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $23 | $15.80 | +45.57% | 3 | Aug 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $90 → $82 | $84.80 | -3.30% | 9 | May 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $100 → $95 | $403.62 | -76.46% | 6 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $300 → $80 | $9.70 | +724.74% | 3 | Dec 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $135 | $142.73 | -5.42% | 2 | Aug 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $8.07 | - | 4 | May 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $20 | $1.30 | +1,438.46% | 4 | May 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $14.69 | - | 2 | Apr 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $127 → $158 | $451.73 | -65.02% | 5 | Nov 8, 2017 |
Avidity Biosciences
Sep 15, 2025
Maintains: Buy
Price Target: $56 → $65
Current: $40.06
Upside: +62.26%
Amylyx Pharmaceuticals
Aug 28, 2025
Maintains: Buy
Price Target: $10 → $14
Current: $12.76
Upside: +9.72%
Vir Biotechnology
Aug 27, 2025
Upgrades: Buy
Price Target: $12 → $14
Current: $4.80
Upside: +191.67%
Acumen Pharmaceuticals
Aug 25, 2025
Maintains: Buy
Price Target: $10 → $9
Current: $1.25
Upside: +620.00%
Amgen
Aug 6, 2025
Maintains: Neutral
Price Target: $305 → $310
Current: $274.71
Upside: +12.85%
Biogen
Aug 1, 2025
Maintains: Neutral
Price Target: $125 → $135
Current: $144.87
Upside: -6.81%
PTC Therapeutics
Jul 28, 2025
Maintains: Neutral
Price Target: $40 → $50
Current: $60.65
Upside: -17.56%
CRISPR Therapeutics AG
Jul 22, 2025
Maintains: Buy
Price Target: $79 → $78
Current: $59.07
Upside: +32.05%
Royalty Pharma
Jul 22, 2025
Maintains: Buy
Price Target: $40 → $42
Current: $35.63
Upside: +17.89%
BridgeBio Pharma
Jun 25, 2025
Maintains: Buy
Price Target: $50 → $54
Current: $51.29
Upside: +5.28%
Jun 17, 2025
Initiates: Buy
Price Target: $72
Current: $59.17
Upside: +21.68%
Jun 17, 2025
Initiates: Buy
Price Target: $42
Current: $24.49
Upside: +71.50%
Jun 17, 2025
Initiates: Buy
Price Target: $110
Current: $76.42
Upside: +43.94%
Jun 17, 2025
Initiates: Sell
Price Target: $6
Current: $8.39
Upside: -28.49%
Jun 2, 2025
Maintains: Buy
Price Target: $700 → $650
Current: $585.50
Upside: +11.02%
May 14, 2025
Downgrades: Neutral
Price Target: $210 → $205
Current: $220.81
Upside: -7.16%
May 12, 2025
Maintains: Neutral
Price Target: $47 → $44
Current: $47.87
Upside: -8.08%
May 6, 2025
Maintains: Buy
Price Target: $145 → $140
Current: $98.15
Upside: +42.64%
Apr 2, 2025
Downgrades: Underperform
Price Target: $7 → $1
Current: $1.45
Upside: -31.03%
Mar 13, 2025
Initiates: Neutral
Price Target: $40
Current: $25.00
Upside: +60.00%
Mar 13, 2025
Initiates: Buy
Price Target: $40
Current: $35.37
Upside: +13.09%
Mar 13, 2025
Initiates: Buy
Price Target: $95
Current: $37.57
Upside: +152.86%
Mar 13, 2025
Initiates: Buy
Price Target: $25
Current: $8.10
Upside: +208.83%
Feb 20, 2025
Maintains: Buy
Price Target: $99 → $103
Current: $54.39
Upside: +89.37%
Jan 7, 2025
Downgrades: Underperform
Price Target: $112 → $4
Current: $2.90
Upside: +37.93%
Nov 14, 2024
Initiates: Buy
Price Target: $125
Current: $112.26
Upside: +11.35%
Nov 14, 2024
Initiates: Buy
Price Target: $575
Current: $387.15
Upside: +48.52%
Oct 31, 2024
Maintains: Buy
Price Target: $1,150 → $1,100
Current: $760.13
Upside: +44.71%
Oct 30, 2024
Downgrades: Underperform
Price Target: $120 → $20
Current: $12.04
Upside: +66.11%
Oct 18, 2024
Upgrades: Buy
Price Target: $22 → $31
Current: $12.21
Upside: +153.89%
Jul 31, 2024
Maintains: Buy
Price Target: $150 → $145
Current: $81.14
Upside: +78.70%
Apr 17, 2024
Maintains: Neutral
Price Target: $180 → $170
Current: $177.20
Upside: -4.06%
Mar 13, 2024
Maintains: Buy
Price Target: $24 → $48
Current: $23.46
Upside: +104.60%
Jan 3, 2024
Downgrades: Neutral
Price Target: $68 → $60
Current: $46.15
Upside: +30.01%
Aug 21, 2023
Maintains: Underperform
Price Target: $10 → $8
Current: $5.36
Upside: +49.25%
Aug 21, 2023
Maintains: Buy
Price Target: $19 → $17
Current: $0.47
Upside: +3,513.95%
Apr 21, 2023
Maintains: Neutral
Price Target: $50 → $45
Current: $24.05
Upside: +87.11%
Nov 1, 2022
Downgrades: Underperform
Price Target: $24
Current: $2.18
Upside: +1,000.92%
Jun 8, 2022
Downgrades: Neutral
Price Target: $12 → $4
Current: $4.06
Upside: -1.48%
Aug 10, 2021
Initiates: Buy
Price Target: $28
Current: $1.66
Upside: +1,591.84%
Jul 13, 2021
Initiates: Buy
Price Target: $34
Current: $0.50
Upside: +6,768.69%
Jan 15, 2021
Downgrades: Neutral
Price Target: $35
Current: $2.72
Upside: +1,189.13%
Nov 23, 2020
Initiates: Buy
Price Target: $525
Current: $2.86
Upside: +18,251.51%
Oct 20, 2020
Initiates: Buy
Price Target: $42
Current: $1.30
Upside: +3,143.24%
Sep 15, 2020
Reinstates: Buy
Price Target: $20
Current: $7.31
Upside: +173.60%
Sep 8, 2020
Reinstates: Buy
Price Target: $20
Current: $0.51
Upside: +3,800.92%
Jun 25, 2020
Reinstates: Underperform
Price Target: $9
Current: $4.34
Upside: +107.37%
Jun 25, 2020
Reinstates: Buy
Price Target: $60
Current: $9.00
Upside: +566.67%
Jun 25, 2020
Initiates: Underperform
Price Target: $7
Current: $4.15
Upside: +68.67%
Aug 5, 2019
Maintains: Equal-Weight
Price Target: $15 → $23
Current: $15.80
Upside: +45.57%
May 3, 2019
Downgrades: Equal-Weight
Price Target: $90 → $82
Current: $84.80
Upside: -3.30%
Mar 1, 2019
Maintains: Underweight
Price Target: $100 → $95
Current: $403.62
Upside: -76.46%
Dec 20, 2018
Downgrades: Equal-Weight
Price Target: $300 → $80
Current: $9.70
Upside: +724.74%
Aug 1, 2018
Maintains: Overweight
Price Target: $100 → $135
Current: $142.73
Upside: -5.42%
May 21, 2018
Downgrades: Underweight
Price Target: n/a
Current: $8.07
Upside: -
May 3, 2018
Maintains: Equal-Weight
Price Target: $16 → $20
Current: $1.30
Upside: +1,438.46%
Apr 5, 2018
Downgrades: Equal-Weight
Price Target: n/a
Current: $14.69
Upside: -
Nov 8, 2017
Maintains: Overweight
Price Target: $127 → $158
Current: $451.73
Upside: -65.02%